Yüklüyor......
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer
OBJECTIVE. To evaluate the utility of amiodarone and its derivative dronedarone as novel drug repositioning candidates in EOC and to determine the potential pathways targeted by these drugs. METHODS. Drug-predict bioinformatics platform was used to assess the utility of amiodarone as a novel drug-re...
Kaydedildi:
| Yayımlandı: | Gynecol Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526024/ https://ncbi.nlm.nih.gov/pubmed/30301560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.09.019 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|